MapLight Therapeutics Inc. Common Stock (MPLT)
Stock · NASDAQ · Health Care
$12.6as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$17.15
Industry
Biotechnology: Pharmaceutical Preparations
About MPLT
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spe…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 133
- Website
- maplightrx.com/
Fundamentals
- 1-day range
- $12.2$12.84
- Market cap
- $569.09M
- P/E (trailing)
- —
- P/E (forward)
- -3.78
- EPS (trailing)
- $-12.47
- Dividend yield
- —
- Beta
- 0.80
- Avg. volume
- 842.8K
52-week range
$9.1$40.43
Next earnings: November 12, 2026 · EPS estimate $-1.09
Forecasts
13 analyst ratings
Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$45
+257.1%
Median
$25
+98.4%
Low
$13
+3.2%
MapLight Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- MPLTMapLight Therapeutics Inc. Common Stock$12.64▲ 0.80%Market cap $569.09MP/E —$9.1$40.43
- CBIOCrescent Biopharma Inc. Common Stock$17.74▼ 0.14%Market cap $552.33MP/E —$8.72$27.41
- CRMDCorMedix Inc. Common Stock$8.31▼ 0.06%Market cap $592.31MP/E 3.53$6.13$14.96
- ARVNArvinas Inc. Common Stock$9.16▼ 0.87%Market cap $520.04MP/E 62.96$6.97$14.51
- BBOTBridgeBio Oncology Therapeutics Inc. Common Stock$8.74▼ 4.79%Market cap $660.88MP/E —$7$14.87
- CLYMClimb Bio Inc. Common Stock$14.56▼ 3.32%Market cap $676.28MP/E —$1.54$18.33
- QTTBQ32 Bio Inc. Common Stock$15.01▼ 7.06%Market cap $451.37MP/E 15.71$1.62$23.57
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MPLT MapLight Therapeutics Inc. Common Stock | $569.09M | — | $12.64 | ▲ 0.80% | $9.1$40.43 |
| CBIO Crescent Biopharma Inc. Common Stock | $552.33M | — | $17.74 | ▼ 0.14% | $8.72$27.41 |
| CRMD CorMedix Inc. Common Stock | $592.31M | 3.53 | $8.31 | ▼ 0.06% | $6.13$14.96 |
| ARVN Arvinas Inc. Common Stock | $520.04M | 62.96 | $9.16 | ▼ 0.87% | $6.97$14.51 |
| BBOT BridgeBio Oncology Therapeutics Inc. Common Stock | $660.88M | — | $8.74 | ▼ 4.79% | $7$14.87 |
| CLYM Climb Bio Inc. Common Stock | $676.28M | — | $14.56 | ▼ 3.32% | $1.54$18.33 |
| QTTB Q32 Bio Inc. Common Stock | $451.37M | 15.71 | $15.01 | ▼ 7.06% | $1.62$23.57 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →Acquired
1.22M
Disposed
80.8K
- Lillie James Woodruff · August 3, 2026 · Sale22.1K @ $12.54
- Catalyst4, Inc. · July 30, 2026 · Buy1.00M @ $13
- Catalyst4, Inc. · July 29, 2026 · Buy3.0K @ $12.63
- Catalyst4, Inc. · July 28, 2026 · Buy65.1K @ $11.69
- Catalyst4, Inc. · July 28, 2026 · Buy141.1K @ $10.74
- Troy Cox · July 28, 2026 · Buy15.6K @ $9.52
- Foff Erin Pennock · July 17, 2026 · Sale3.7K @ $37.9
- Hanson Kristopher · July 17, 2026 · Sale1.1K @ $37.9
- Lillie James Woodruff · July 17, 2026 · Sale2.1K @ $37.9
- Kroeger Christopher A. · July 17, 2026 · Sale16.8K @ $37.9
- Kreitzer Anatol · July 17, 2026 · Sale200 @ $38.39
- Kreitzer Anatol · July 17, 2026 · Sale14.1K @ $37.7
- Kreitzer Anatol · July 17, 2026 · Sale2.8K @ $37.05
- GILLIS JONATHAN · July 17, 2026 · Sale900 @ $38.17
- GILLIS JONATHAN · July 17, 2026 · Sale17.0K @ $37.61
Institutional Ownership
March 31, 2026
- Total shares held
- 24.44M
- Total value held
- $437.68M
- Institutional holders
- 77
Top holders this quarter
- Unknown3.69M
- Unknown3.23M
- Unknown2.80M
- Unknown1.99M
- Unknown1.34M
- Unknown1.01M
- Unknown971.3K
- Unknown950.0K
- Unknown912.0K
- Unknown719.8K
See the full, filterable feed with live charts on the MarketWall dashboard.